MA
BSX icon

MCF Advisors’s Boston Scientific BSX Stock Holding History

MCF Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.9K Sell
372
-303
-45% -$16.5K ﹤0.01% 949
2026
Q1 		$42.4K Buy
675
+330
+96% +$26.4K ﹤0.01% 636
2025
Q4 		$32.9K Buy
345
+93
+37% +$9.12K ﹤0.01% 590
2025
Q3 		$24.6K Buy
252
+42
+20% +$4.35K ﹤0.01% 549
2025
Q2 		$22.6K Hold
210
– – ﹤0.01% 538
2025
Q1 		$21.2K Sell
210
-62
-23% -$6.24K ﹤0.01% 538
2024
Q4 		$24.3K Sell
272
-5
-2% -$440 ﹤0.01% 523
2024
Q3 		$23.2K Buy
277
+137
+98% +$10.8K ﹤0.01% 520
2024
Q2 		$10.8K Hold
140
– – ﹤0.01% 628
2024
Q1 		$9.59K Buy
140
+12
+9% +$772 ﹤0.01% 630
2023
Q4 		$7.4K Hold
128
– – ﹤0.01% 630
2023
Q3 		$6.76K Buy
128
+66
+106% +$3.46K ﹤0.01% 627
2023
Q2 		$3.35K Hold
62
– – ﹤0.01% 663
2023
Q1 		$3.1K Hold
62
– – ﹤0.01% 666
2022
Q4 		$2.87K Hold
62
– – ﹤0.01% 644
2022
Q3 		$2K Hold
62
– – ﹤0.01% 667
2022
Q2 		$2K Hold
62
– – ﹤0.01% 612
2022
Q1 		$3K Buy
+62
New +$2.69K ﹤0.01% 589
2021
Q4 		– Sell
-62
Closed -$3K – 127
2021
Q3 		$3K Buy
+62
New +$2.74K ﹤0.01% 559

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MCF Advisors's BSX Position: Q2 2026 in Review

MCF Advisors reduced its Boston Scientific (BSX) stake by 45% in Q2 2026, selling an estimated $16.5K and leaving 372 shares worth $15.9K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

MCF Advisors first reported a position in BSX in Q3 2021 and has held it in 19 quarters since. The position peaked at $42.4K in Q1 2026. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • MCF Advisors held 372 shares of Boston Scientific worth $15.9K as of Q2 2026.
  • MCF Advisors sold 303 Boston Scientific shares in Q2 2026, an estimated $16.5K.
  • Boston Scientific made up ﹤0.01% of MCF Advisors's portfolio in Q2 2026, its #949 holding.
  • MCF Advisors first reported a position in Boston Scientific in Q3 2021 and has held it in 19 quarters since.
  • MCF Advisors's Boston Scientific position peaked at $42.4K in Q1 2026.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on MCF Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.